Zogenix neurology news
A judge in the U.S. District Court for the District of Massachusetts granted Zogenix's motion for a preliminary injunction thus stopping Massachusetts' statewide ban on Zogenix's pain drug Zohydro ER hydrocodone bitartrate. Zogenix said the preliminary injunction becomes effective on April 22, after which Zohydro ER will be available in Massachusetts while the suit is ongoing. There are no scheduled upcoming hearings listed on the docket for the suit.
Earlier this month, Zogenix filed the suit - Zogenix, Inc. v. Patrick - challenging Massachusetts Gov. Deval Patrick's executive order banning the prescription or distribution of Zohydro ER hydrocodone bitartrate to treat pain. On March 28, Patrick declared opiate addiction a public health emergency and directed state authorities to immediately prohibit the prescription or sale of Zohydro ER until FDA approves an abuse-deterrent formulation. Zogenix launched Zohydro ER - an oral, non-abuse deterrent, extended-release (ER) formulation of hydrocodone - in select pharmacies in March (see BioCentury, March 31 & April 14). ...